ArticleEMBO molecular medicine2020

Tumors defective in homologous recombination rely on oxidative metabolism: relevance to treatments with PARP inhibitors.

Álvaro Lahiguera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.